Physician profile
Andrew E Park
NPI 1598722654
$303,798.63
in general payments reported to CMS, 2019-2025
36 companies · $718 in 2025
The $718 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88K · 2020: $84K · 2021: $88K · 2022: $41K · 2023: $1,121 · 2024: $524 · 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,738 · Consulting Fee: $500 · Gift: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,738.35 |
| Consulting Fee | $500.00 |
| Gift | $125.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $298,016.92 | 2019-2022 | |
| Camber Spine Technologies LLC | $1,267.12 | 2022 | |
| Stryker Corporation | $775.81 | 2019-2025 | Tritanium, N/A |
| Nexus Spine, LLC | $625.84 | 2023 | Presson |
| Medtronic USA, INC. | $621.04 | 2019-2020 | |
| Xenix Medical LLC | $254.64 | 2024-2025 | |
| Vb Spine LLC | $217.21 | 2025 | Capri Corpectomy Cage System |
| Arteriocyte Medical Systems, INC. | $192.76 | 2023 | Magellan |
| Intrinsic Therapeutics | $191.05 | 2025 | Barricaid Acd (Annular Closure Device) |
| Gs Solutions, INC. | $153.02 | 2024 | |
| Smith+Nephew, INC. | $145.78 | 2019 | |
| Dendreon Pharmaceuticals LLC | $144.63 | 2019 | |
| Cerapedics INC. | $141.47 | 2022 | |
| Woven Orthopedic Technologies, LLC | $131.00 | 2024 | |
| Depuy Synthes Sales INC. | $107.49 | 2023-2025 | Fibergraft Aeridyan Matrix, Expedium, Spine & Trauma 3d Navigation |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corelink, LLC | $100.00 | 2022 | |
| Abbvie INC. | $87.00 | 2021 | |
| Coloplast Corp | $72.25 | 2020-2021 | |
| Augmedics INC. | $70.90 | 2024 | Xvision |
| Seaspine Orthopedics Corporation | $66.65 | 2019 | |
| Pfizer INC. | $52.42 | 2021 | |
| Spine Wave, INC. | $50.79 | 2023 | Annex Adjacent Level System |
| Providence Medical Technology, INC. | $41.66 | 2023 | |
| Life Spine, INC. | $41.65 | 2022-2025 | Plateau Spacer System, Prolift Lateral, Arx Sai |
| Globus Medical, INC. | $36.28 | 2024 | Hedron Ia, Hedron C |
| Astellas Pharma US INC | $35.97 | 2019 | |
| Curiteva, INC. | $34.00 | 2021 | |
| Si-Bone, INC. | $22.95 | 2025 | |
| Innovation Technologies INC | $19.55 | 2022 | |
| Integra Lifesciences Corporation | $17.72 | 2020 | |
| Surgalign Spine Technologies, INC. | $15.22 | 2022 | |
| Ethicon US, LLC | $14.57 | 2025 | Surgiflo Hemostatic Matrix, Vistaseal, Surgicel Nu-Knit |
| Axis Spine Technologies INC. | $14.24 | 2022 | |
| Expanding Innovations, INC. | $11.83 | 2025 | X-Pac |
| Orthofix Medical, INC. | $7.20 | 2025 | Cervical-Stim |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.